Paper36949202
CFTR function, pathology and pharmacology at single-molecule resolution.
Levring J and 5 others. Nature, 2023. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. CFTR function, pathology and pharmacology at single-molecule resolution. Papers, record 36949202. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949202
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Cystic Fibrosis Transmembrane Conductance Regulator | Major topic |
| Humans | |
| Adenosine Triphosphatases | |
| Adenosine Triphosphate | |
| Allosteric Regulation | |
| Chlorides | |
| Electric Conductivity | |
| Electrophysiology | |
| Fluorescence Resonance Energy Transfer | |
| Ion Channel Gating | |
| Protein Multimerization | |
| Aminophenols | |
| Quinolones | |
| Pyrans | |
| Pyrazoles |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 GM098859 | NIGMS NIH HHS | United States | R01GM098859 | PubMed and NIH | NIH RePORTER |
| R01GM079238 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 37142783 | Author Correction: CFTR function, pathology and pharmacology at single-molecule resolution. | https://conductscience.org/library/papers/37142783 |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25404111 | Cystic fibrosis genetics: from molecular understanding to clinical application. | Nat Rev Genet | 2015 | https://conductscience.org/library/papers/25404111 | PubMed |
| 2 | 2475911 | Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. | Science | 1989 | https://conductscience.org/library/papers/2475911 | PubMed |
| 3 | 2772657 | Identification of the cystic fibrosis gene: chromosome walking and jumping. | Science | 1989 | https://conductscience.org/library/papers/2772657 | PubMed |
| 4 | 16554808 | The ABC protein turned chloride channel whose failure causes cystic fibrosis. | Nature | 2006 | https://conductscience.org/library/papers/16554808 | PubMed |
| 5 | 30516439 | STRUCTURE, GATING, AND REGULATION OF THE CFTR ANION CHANNEL. | Physiol Rev | 2019 | https://conductscience.org/library/papers/30516439 | PubMed |
| 6 | 29581173 | Structural mechanisms of CFTR function and dysfunction. | J Gen Physiol | 2018 | https://conductscience.org/library/papers/29581173 | PubMed |
| 7 | 1716180 | Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. | Cell | 1991 | https://conductscience.org/library/papers/1716180 | PubMed |
| 8 | 7530246 | The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7530246 | PubMed |
| 9 | 11861646 | The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11861646 | PubMed |
| 10 | 19966305 | Strict coupling between CFTR's catalytic cycle and gating of its Cl- ion pore revealed by distributions of open channel burst durations. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/19966305 | PubMed |
| 11 | 20876359 | Involvement of F1296 and N1303 of CFTR in induced-fit conformational change in response to ATP binding at NBD2. | J Gen Physiol | 2010 | https://conductscience.org/library/papers/20876359 | PubMed |
| 12 | 20133716 | ATP-independent CFTR channel gating and allosteric modulation by phosphorylation. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133716 | PubMed |
| 13 | 28340353 | Molecular Structure of the Human CFTR Ion Channel. | Cell | 2017 | https://conductscience.org/library/papers/28340353 | PubMed |
| 14 | 30459277 | Molecular structure of the ATP-bound, phosphorylated human CFTR. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30459277 | PubMed |
| 15 | 15729345 | CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. | Nature | 2005 | https://conductscience.org/library/papers/15729345 | PubMed |
| 16 | 12508051 | On the mechanism of MgATP-dependent gating of CFTR Cl- channels. | J Gen Physiol | 2003 | https://conductscience.org/library/papers/12508051 | PubMed |
| 17 | 25825169 | Cysteine accessibility probes timing and extent of NBD separation along the dimer interface in gating CFTR channels. | J Gen Physiol | 2015 | https://conductscience.org/library/papers/25825169 | PubMed |
| 18 | 20421370 | Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel. | J Gen Physiol | 2010 | https://conductscience.org/library/papers/20421370 | PubMed |
| 19 | 23223629 | Nonequilibrium gating of CFTR on an equilibrium theme. | Physiology (Bethesda) | 2012 | https://conductscience.org/library/papers/23223629 | PubMed |
| 20 | 32913060 | Tuning the Baird aromatic triplet-state energy of cyclooctatetraene to maximize the self-healing mechanism in organic fluorophores. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32913060 | PubMed |
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819878 | Mechanistic Insights into CFTR Potentiation by the Antimicrobial Peptide Esc(1-21): Direct Interaction with the NBD1-NBD2 Interface. | ACS Omega | 2026 | https://conductscience.org/library/papers/42819878 | PubMed |
| 42737613 | Comparative Alignment of CFTR2 and CFTR-France Classifications with a Turkish Cystic Fibrosis Referral Cohort. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737613 | PubMed |
| 42654157 | Combining Gene Therapy with Current Modulator Treatments for Cystic Fibrosis: A Promising Area of Research. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654157 | PubMed |
| 42601390 | Triple potentiator combinations increase the functional correction of several CFTR gating mutants. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42601390 | PubMed |
| 42535643 | ATP-driven conformational dynamics reveal hidden intermediates in a heterodimeric ABC transporter. | Elife | 2026 | https://conductscience.org/library/papers/42535643 | PubMed |
| 42396207 | Optimal parameterization of nonequilibrium generalized master equations from discrete-time experimental data. | ArXiv | 2026 | https://conductscience.org/library/papers/42396207 | PubMed |
| 42353213 | Cellular Models and Functional Assays for Assessing CFTR Function: A Comprehensive Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353213 | PubMed |
| 42302461 | Dual-mechanism therapy for chronic rhinosinusitis via siRNA targeting of bacterial 16S rRNA and disruption of CFTR-pathogen interactions. | Braz J Otorhinolaryngol | 2026 | https://conductscience.org/library/papers/42302461 | PubMed |
| 41920076 | Altered functional interactions between CFTR disease mutants ΔF508 and G551D and the protein kinase A catalytic subunit. | J Physiol | 2026 | https://conductscience.org/library/papers/41920076 | PubMed |
| 41915736 | Single-molecule dissection of CFTR folding defects and pharmacological rescue. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41915736 | PubMed |
| 41817163 | The systems that transport ions and their impact on sperm function and male fertility. | Function (Oxf) | 2026 | https://conductscience.org/library/papers/41817163 | PubMed |
| 41613863 | Genetically engineered approaches to the treatment of cystic fibrosis. | Biophys Rev | 2025 | https://conductscience.org/library/papers/41613863 | PubMed |
| 41576103 | Chronic and acute modulator treatment restore wild-type-like activity and stability to the primary cystic fibrosis-causing CFTR variant. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41576103 | PubMed |
| 41516108 | HuR-Targeted Small Molecules Reduce Pseudomonas aeruginosa Adhesion in Cystic Fibrosis Airway Epithelial Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516108 | PubMed |
| 41487693 | Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer. | Ther Adv Med Oncol | 2026 | https://conductscience.org/library/papers/41487693 | PubMed |
| 41381597 | Seminal fluid extracellular vesicles restore human sperm osmoregulation after cystic fibrosis transmembrane conductance regulator inhibition. | Sci Rep | 2025 | https://conductscience.org/library/papers/41381597 | PubMed |
| 41331139 | Parallel stopped-flow interrogation of diverse biological systems at the single-molecule scale. | Nat Methods | 2026 | https://conductscience.org/library/papers/41331139 | PubMed |
| 41330381 | Cystic fibrosis risk variants confer protection against inflammatory bowel disease. | Cell Genom | 2026 | https://conductscience.org/library/papers/41330381 | PubMed |
| 41258017 | In vivo conformational space and defects of misfolded CFTR variants by covalent protein painting. | Nat Commun | 2025 | https://conductscience.org/library/papers/41258017 | PubMed |
| 41155173 | Targeting the Aryl Hydrocarbon Receptor: The Potential of Indole Compounds in the Treatment of Cystic Fibrosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155173 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 | NCBI Gene |
| DNAH8 | 1769 | PubTator's text mining | https://conductscience.org/library/genes/1769 | NCBI Gene |
| NEB | 4703 | PubTator's text mining | https://conductscience.org/library/genes/4703 | NCBI Gene |
| TSPAN16 | 26526 | PubTator's text mining | https://conductscience.org/library/genes/26526 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36949202
GET https://conductscience.org/api/papers/v1/36949202/references?page=2